Incyclix Bio is a North Carolina-based biotechnology company that develops and commercializes next-generation cell cycle control treatments for cancer diseases.
Business Model:
Revenue: $124.4k
Employees: 2-10
Address: 600 Park Offices Drive
City: Research Triangle Park
State: NC
Zip: 27709
Country: US
Incyclix Bio is a North Carolina-based biotechnology company that develops and commercializes next-generation cell cycle control treatments for cancer diseases.
Contact Phone:
+19193280003
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2020 | Venture Round | $0 |
Eshelman Ventures Eshelman Ventures |
3/2022 | Series B | $0 |
Boxer Capital Eshelman Ventures RA Capital Management Boxer Capital Eshelman Ventures RA Capital Management |
3/2022 | Series B | 3 | $30M |
Boxer Capital RA Capital Management Eshelman Ventures Boxer Capital Eshelman Ventures RA Capital Management |
8/2020 | Venture Round | 1 | $6M |
Eshelman Ventures Eshelman Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|